$Longeveron (LGVN.US)$ let's go again! lol
3
$Longeveron (LGVN.US)$ that's the power of pine-sol baby
1
Elizabeth G
reacted to
$bluebird bio (BLUE.US)$ FDA will not approve a drug treatment if its safety and efficacy profile yield no statistical significance. It is important to read the entire FDA approval of the drug on company website instead of believing what these malicious posters do to make the stock crash on such a VERY IMPT TREATMENT MILESTONE of SCD.
3
2
Elizabeth G
liked
$bluebird bio (BLUE.US)$ It is just a blackbox warning, not the regular side effect of medication.
From the website and I quote:
“The most common adverse reactions ≥ Grade 3 (incidence ≥ 20%) were stomatitis, thrombocytopenia, neutropenia, febrile neutropenia, anemia, and leukopenia. As previously reported, three patients died during LYFGENIA clinical trials; one from sudden cardiac death due to underlying disease and two from acute myeloid leukemia who were treated with an earlier version of LY...
From the website and I quote:
“The most common adverse reactions ≥ Grade 3 (incidence ≥ 20%) were stomatitis, thrombocytopenia, neutropenia, febrile neutropenia, anemia, and leukopenia. As previously reported, three patients died during LYFGENIA clinical trials; one from sudden cardiac death due to underlying disease and two from acute myeloid leukemia who were treated with an earlier version of LY...
2
1
Elizabeth G
liked
$Clearmind Medicine (CMND.US)$ this needs to break out here. if not there is something massively wrong. please keep a close watch. i dont know whats going on behind the scenes but I am getting suspicious. Technical set up is bullish. However if it breaks support its very bad.
4
9
Elizabeth G
liked
$LQR House (LQR.US)$ Float is finally correct here on moo moo. 3.12 million shares is still very tiny. Buying pressure will make this Explode YmUpwards
4
6